Similar safety results of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) from a phase III trial in patients (pts) with previously untreated advanced gastric cancer (AGC)

被引：0
|
作者：
Kang, Y. K.
Kang, W. K.
Shin, D. B.
Chen, J.
Xiong, J.
Wang, J.
Lichinitser, M.
Salas, M. P.
Suarez, T.
Santamaria, J.
机构：
[1] Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Samsung Med Ctr, Dept Internal Med, Ilwon Dong, South Korea
[3] Gachon Med Sch, Gil Med Ctr, Dept Internal Med, Guwal Dong, South Korea
[4] Jiangsu Canc Hosp, Jiangsu, Peoples R China
[5] 1st Affiliated Hosp, Jianxi Med Coll, Jianxi, Peoples R China
[6] Shanghai Changzheng Hosp, Shanghai, Peoples R China
[7] Russian Canc Res Ctr, Blokhin Canc Res Ctr, Moscow, Russia
[8] Hosp Sabogal, Lima, Peru
[9] Ctr Med Pensiones, Yucatan, Mexico
[10] Inst Oncol Nacl, Ancon, Panama
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [1] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M.
    Suarez, T.
    Santamaria, J.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 19 - 19
  • [2] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results.
    Kang, Y.
    Kang, W. K.
    Shin, D. B.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Salas, M. P.
    Suarez, T.
    Santamaria, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 183S - 183S
  • [3] Capecitabine/cisplatin vs. continuous infusion of 5-FU/cisplatin as first-line therapy in patients (pts) with advanced gastric cancer (AGC):: a randomised phase III trial
    Kang, Y.
    Kang, W.
    Shin, D.
    Chen, J.
    Xiong, J.
    Wang, J.
    Lichinitser, M.
    Philco, M.
    Suarez, T.
    Santamaria, J.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 259 - 259
  • [4] Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (PTS) with advanced gastric cancer (AGC):: Subgroup analyses confirm main efficacy findings
    Kang, Yoon Koo
    Kang, Won Ki
    Shin, Dong Bok
    Chen, Jia
    Xiong, Jianping
    Wang, Jie Jun
    Lichinitser, Mikhail
    Philco, Manuel
    Suarez, Tirso
    Santamaria, Julio
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 308 - 308
  • [5] Pharmacoeconomic analysis of treating advanced gastric cancer (AGC) with capecitabine/cisplatin (XP) vs. 5-FU/cisplatin (FP) regimens in an Italian setting
    Garrison, L. P.
    Cirrincione, A.
    Giuliani, G.
    [J]. VALUE IN HEALTH, 2007, 10 (03) : A127 - A127
  • [6] Economic evaluation of the cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin (XP) vs. 5-FU/cisplatin (FP) regimens in an Italian setting
    Giuliani, G.
    Falcone, A.
    Garrison, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] COST MINIMIZATION ANALYSIS (CMA) OF CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN ADVANCED GASTRIC CANCER (AGC) TREATMENT IN THE ROMANIAN SETTING
    Curescu, S.
    Stanculeanu, D. L.
    Croitoru, A.
    Radu, C. P.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A453 - A453
  • [8] COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING
    Kawalec, P.
    Szawlowski, A.
    Federowicz, I
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A473 - A473
  • [9] Cost of treating advanced gastric cancer (AGC) with capecitabine/cisplatin vs. 5-FU/cisplatin regimens: An economic evaluation from an Italian perspective
    Giuliani, G.
    Falcone, A.
    Cirrincione, A.
    Garrison, L.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 265 - 265
  • [10] Phase I Irinotecan, Cisplatin and protracted infusion 5-FU (ICF) in advanced gastric cancer (AGC)
    Fernandez Martos, Carlos
    Segura, Angel
    Aparicio, Jorge
    Molins, Carmen
    Busquier, Isabel
    Poveda, Andres
    Balcells, Miquel
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 238 - 238
12345